ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2025
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • 2020-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstracts tagged "Collagen"

  • Abstract Number: 1019 • 2018 ACR/ARHP Annual Meeting

    Involvement of Mast Cells in the Pathogenesis of Sjögren’s Syndrome By Induction of Tissue Fibrosis Via Fibroblast Collagen Synthesis

    Shinjiro Kaieda1, Kyoko Fujimoto2, Masaki Tominaga3, Masaki Okamoto4, Tomoaki Hoshino5 and Hiroaki Ida6, 1Department of Medicine, *Division of Respirology, Neurology and Rheumatology, Kurume University School of Medicine, kurume, Japan, 2Division of Respirology, Neurology and Rheumatology, Kurume University School of Medicine, Kurume, Japan, 3Kurume University School of Medicine, Kurume, Japan, 4Medicine, Kurume University School of Medicine, Kurume, Japan, 5Department of Medicine, Division of Respirology, Neurology and Rheumatology, Kurume University School of Medicine, Kurume, Japan, 6Respiorogy, Neurology and Rheumatology, Kurume University School of Medicine, Kurume, Japan

    Background/Purpose: There is an emerging view that mast cells may play a pivotal role in several inflammatory and autoimmune diseases. However, the role of mast…
  • Abstract Number: 465 • 2017 ACR/ARHP Annual Meeting

    Basement Membrane Remodeling in Rheumatoid Arthritis Associates with Disease Activity, Response to IL-6 Inhibitor Treatment and Radiographic Progression: Analysis of Two Phase III Clinical Trials

    Natasja Stæhr Gudman1, Pernille Juhl1, Christian S. Thudium2, Peter Junker3, Anne Sofie Siebuhr4, Inger Byrjalsen1, Morten Karsdal5 and Anne C. Bay-Jensen4, 1Nordic Bioscience, Herlev, Denmark, 2Biomarkers and Research, Nordic Bioscience, Herlev, Denmark, 3Department of Rheumatology C, Odense University Hospital, Odense, Denmark, 4Rheumatology, Nordic Bioscience, Herlev, Denmark, 5Biomarkers and Reseacrh, Nordic Bioscience, Herlev, Denmark

    Background/Purpose: Rheumatoid arthritis (RA) is associated with neovascularization of the synovial membrane and increased risk of cardiovascular co-morbidity. The extra cellular matrix below the endothelial…
  • Abstract Number: 489 • 2017 ACR/ARHP Annual Meeting

    Endotypic Clustering of Rheumatoid Arthritis Patients through the Use of Tissue Specific Serum Biomarkers Identifies Structural Progressors

    Joseph Patrick Michele Blair1, Cecilie Liv Bager1, Line Mærsk Staunstrup1, Henning Bay Nielsen1, Morten Karsdal2 and Anne-C. Bay-Jensen3, 1ProScion, Herlev, Denmark, 2Biomarkers and Reseacrh, Nordic Bioscience, Herlev, Denmark, 3Biomarkers and Reseach, Nordic Bioscience, Herlev, Denmark

    Background/Purpose: Treatment of RA patients is guided by measures of disease activity such as DAS28, best practice recommendation, and less often by a treat-to-target approach.…
  • Abstract Number: 762 • 2017 ACR/ARHP Annual Meeting

    M10, a Caspase Cleavage Product of the Hepatocyte Growth Factor Receptor, Downregulates Bone Morphogenetic Protein-9-Induced Smad1/5/8 Phosphorylation and Collagen Production in Human Lung Fibroblasts

    Atsushi Noguchi, Ilia Atanelishvili, Tanjina Akter, Richard M. Silver and Galina S. Bogatkevich, Division of Rheumatology and Immunology, Department of Medicine, Medical University of South Carolina, Charleston, SC

    Background/Purpose: We recently identified M10, a caspase cleavage product of the hepatocyte growth factor receptor, as an anti-fibrotic peptide that interacts with Smad2 and inhibits…
  • Abstract Number: 1226 • 2017 ACR/ARHP Annual Meeting

    Association of Dorsal Flat Vertebra/Platyspondylia As a Form of Vertebral Dysplasia within Type II Collage Disorders

    Pilar Ahijado-Guzman1, Raul Veiga2, Miguel Cantalejo1, Justo Ruiz3 and Antonio Zapatero3, 1Rheumatology Unit. Fuenlabrada’s Hospital, Madrid, Madrid, Spain, 2Rheumatology Unit. Fuenlabrada’s Hospital, Madrid, Fuenlabrada, Spain, 3Department of Internal Medicine. Fuenlabrada’s Hospital, Madrid, Madrid, Spain

    Background/Purpose: Defects in the type II collagen gene are described. These predispose humans to various phenotypic combinations in families with skeletal dysplasia, and/or disease by…
  • Abstract Number: 1725 • 2017 ACR/ARHP Annual Meeting

    Insulin-like Growth Factor Binding Protein-4 Exerts Anti-Fibrotic Effects and Its Levels Are Reduced in SSc-Associated Lung Fibrosis

    Yunyun Su1, Stanley Hoffman2 and Carol A. Feghali-Bostwick3, 1Medicine, Division of Rheumatology and Immunology, Medical University of South Carolina, charleston, SC, 2Division of Rheumatology and Immunology, Medical University of South Carolina, Charleston, SC, 3Division of Rheumatology and Immunology, Division of Rheumatology and Immunology, Medical University of South Carolina, Charleston, SC, United States, Charleston, SC

    Background/Purpose: The Insulin-like growth factor (IGF) system plays an important role in cellular growth, proliferation, differentiation, apoptosis and transformation; IGF binding proteins (IGFBP) exert cell…
  • Abstract Number: 1930 • 2017 ACR/ARHP Annual Meeting

    Interleukin 1β Decreases Capacity for Repair Human Cartilage Lesions By Mesenchymal Stromal Cells on Collagen/Proteoglycan Scaffolds

    Clara Sanjurjo-Rodríguez1, ROCÍO CASTRO-VIÑUELAS2, Tamara Hermida-Gómez3, ISAAC FUENTES BOQUETE4, Francisco Javier De Toro Santos5, Francisco J Blanco6 and SILVIA MARIA DÍAZ-PRADO4, 1of Biomedical Sciences, Medicine and Physiotherapy., Cell Therapy and Regenerative Medicine Group. Universidade da Coruña. INIBIC. CIBER-BBN., A CORUÑA, Spain, 2Biomedical Sciences. Medicine and Physiotherapy, Cell Therapy and Regenerative Medicine Group. Universidade da Coruña. INIBIC., A CORUÑA, Spain, 3Rheumatology, INIBIC. Complexo Hospitalario Universitario de A Coruña (CHUAC), Sergas. CIBER-BBN., A Coruña, Spain, 4Biomedical Sciences, Medicine and Physiotherapy, Cell Therapy and Regenerative Medicine Group. Universidade da Coruña. INIBIC. CIBER-BBN., A CORUÑA, Spain, 5Reumatology, Cell Therapy and Regenerative Medicine Group. Universidade da Coruña. INIBIC. CIBER-BBN. Complejo Hospitalario Universitario A Coruña (SERGAS)., La Coruña, Spain, 6Servicio de Reumatología. Area Genomica. Instituto de Investigación Biomédica de A Coruña (INIBIC). Complexo Hospitalario Universitario de A Coruña (CHUAC), Sergas. Universidade da Coruña (UDC), A Coruña, Spain

    Background/Purpose: There is controversy about the effect of catabolic cytokines in regenerative medicine. The purpose of this study was to evaluate the effect of interleukin…
  • Abstract Number: 2688 • 2017 ACR/ARHP Annual Meeting

    Collagen Metabolite Biomarker Levels Are Associated with the Amount of Fibrosis in Internal Organs in Systemic Sclerosis Patients

    Anne Sofie Siebuhr1, Satoshi Kubo2, Pernille Juhl3, K Nakano4, S Nakayamada5, Morten Karsdal6, Anne-C. Bay-Jensen7 and Yoshiya Tanaka8, 1the first department of internal medicine, University of occupational and environmental health, Fukuoka, Japan, 2The first department of internal medicine, University of Occupational en environmental Health, Fukuoka, Japan, 3Nordic Bioscience, Herlev, Denmark, 4the first department of internal medicin, University of occupational and environmental health, fukuoka, Japan, 5The first department of internal medicine, University of Occupational and environmental Health, fukuoka, Japan, 6Biomarkers and Reseacrh, Nordic Bioscience, Herlev, Denmark, 7Biomarkers and Reseach, Nordic Bioscience, Herlev, Denmark, 8The First Department of Internal Medicine, University of Occupational and Environmental Health, Kitakyushu, Japan

    Background/Purpose: Biomarkers that can monitor the fibrotic burden will aid in trial enrichment and personalized health care in SSc. SSc is associated with internal organ…
  • Abstract Number: 1857 • 2016 ACR/ARHP Annual Meeting

    A Novel Highly Selective 5-Hydroxytryptamine 2B (5-HT2B) Receptor Antagonist Ameliorating Fibrosis in Preclinical Models of Systemic Sclerosis

    Christina Wenglén1, Lars Pettersson2, Helena Arozenius2 and Gunilla Ekström1, 1R&D, AnaMar AB, Lund, Sweden, 2AnaMar AB, Lund, Sweden

    Background/Purpose:   Methods:   Results:   Conclusion: The results demonstrate that the 5-HT2B receptor antagonist AM1125 prevents pro-fibrotic events in human dermal fibroblasts and attenuates…
  • Abstract Number: 2070 • 2016 ACR/ARHP Annual Meeting

    Long Noncoding RNA H19X Is a Master Regulator of Extracellular Matrix Production in Systemic Sclerosis and Other Fibrotic Disease

    Elena Pachera1, Shervin Assassi2, Gloria Salazar2, Mojca Frank Bertoncelj1, Rucsandra Dobrota1, Matthias Brock3, Fina Kurreeman4, Jeska K. de Vries-Bouwstra4, Tobias Messemaker4, Carol Feghali-Bostwick5, Jeorg HW Distler6, Gabriela Kania1 and Oliver Distler1, 1Department of Rheumatology, University Hospital Zurich, Zurich, Switzerland, 2Department of Internal Medicine - Rheumatology, University of Texas-McGovern Medical School, Houston, TX, 3Department of Pulmonology, University Hospital Zurich, Zurich, Switzerland, 4Department of Rheumatology, Leiden University Medical Center, Leiden, Netherlands, 5Division of Rheumatology and Immunology, Medical University of South Carolina, Charleston, SC, 6Internal Medicine 3, University of Erlangen, Erlangen, Germany

    Background/Purpose:  Long noncoding RNAs (lncRNAs) are an emerging class of large noncoding transcripts involved in the regulation of gene expression in health and disease. We…
  • Abstract Number: 1103 • 2016 ACR/ARHP Annual Meeting

    Gingival Tissue-Derived MSC Cells (GMSC) Suppress Osteoclastogenesis and Bone Erosion in Collagen-Induced Arthritis Thought CD73 Signal Pathway

    Yongjiang Zheng1,2, Julie Wang3, Nancy J. Olsen4, Limin Rong1 and Song Guo Zheng4,5, 1Center for Clinic Immunology, The Third Affiliated Hospital, Sun Yat-sen University, Guangzhou, China, Guangzhou, China, 2Medicine, Penn State University Hershey Medical Center, Hershey, PA, 3Medicine, Penn State Hershey Medical Center, Hershey, PA, 4Medicine/Rheumatology, Penn State Hershey Medical Center, Hershey, PA, 5Medicine/Rheumatology, Penn State University Milton S. Hershey Medical Center, Hershey, PA

    Background/Purpose: Rheumatoid arthritis (RA) is characterized by chronic inflammatory synovitis leading to joint destruction and systemic bone loss. Osteoclasts are responsible for bone destruction in…
  • Abstract Number: 1455 • 2016 ACR/ARHP Annual Meeting

    Collagen-Induced Arthritis and Uveitis in Mice Lacking TNF Receptors

    Chiharu Iwahashi1, Minoru Fujimoto2, Tomoharu Ohkawara3, Hayato Urushima1, Satoshi Serada1 and Tetsuji Naka4, 1Laboratory for Immune Signal, National Institute of Biomedical Innovation, Health and Nutrition, Ibaraki, Japan, 2Laboratry of immune signal, National Institute of Biomedical Innovation, Health and Nutrition, Ibaraki, Japan, 3Laboratory for immune signal, National Institute of Biomedical Innovation, Health and Nutrition, Osaka, Japan, 4Laboratory for immune signal, National Institute of Biomedical Innovation, Health and Nutrition, Ibaraki, Japan

    Background/Purpose: Tumor necrosis factor (TNF) is a critical effector of the autoimmune inflammation in rheumatoid arthritis (RA) and uveitis. TNF inhibitors are preferably used in…
  • Abstract Number: 1652 • 2016 ACR/ARHP Annual Meeting

    Basement Membrane Remodeling Is Significantly Increased with Rheumatoid Arthritis and Suppressed By IL6 Inhibition: Analysis of Two Phase III Clinical Trial

    Natasja Stæhr Gudman1, Pernille Juhl2, Christian S. Thudium3, Anne Sofie Siebuhr4, Inger Byrjalsen5, Morten Asser Karsdal4 and Anne C. Bay-Jensen4, 1Nordic Bioscience A/S, Herlev, Denmark, 2Biomarkers & Research, Nordic Bioscience, Herlev, Denmark, 3Biomarkers and Research, Nordic Bioscience, Herlev, Denmark, 4Rheumatology, Nordic Bioscience, Herlev, Denmark, 5Nordic Bioscience, Clinical Development, Herlev, Denmark

    Background/Purpose: Rheumatoid arthritis (RA) is associated with neovascularization of the synovial membrane and increased risk of cardiovascular disease, consequent to vascular and endothelial dysfunction, which…
  • Abstract Number: 1147 • 2015 ACR/ARHP Annual Meeting

    TGFß1 Blocks Chondrocyte Hypertrophy and Increases Cell Viability in Cultured Cartilage Explants but Does Not Protect Against Proteoglycan Loss

    Arjan van Caam, Wojciech Madej, Henk van Beuningen, Esmeralda Blaney Davidson and Peter van der Kraan, Experimental Rheumatology, Radboud university medical center, Nijmegen, Netherlands

    Background/Purpose: In osteoarthritis, cartilage degradation is partly due to chondrocytes gaining a hypertrophy-like phenotype. TGFβ1 is considered to be a protective factor for articular cartilage by blocking…
  • Abstract Number: 1306 • 2015 ACR/ARHP Annual Meeting

    MRI Erosions in Undifferentiated Arthritis. Different Associations with the Collagen IIA N-Terminal Propeptide (PIIANP) and Galectin-3 in Pre-RA and Other Arthritides

    Saida Farah Issa1, Anne Duer2, Mikkel Østergaard3, Hanne Lindegaard1, Kim Hørslev-Petersen4, Merete Lund Hetland5, Jakob M. Møller6, Anne Friesgaard Christensen7 and Peter Junker1, 1Department of Rheumatology, Odense University Hospital, Odense, Denmark, 2Department of Rheumatology, Copenhagen University Hospital at Hvidovre, Hvidovre, Denmark, 3Center for Rheumatology and Spine Diseases, Glostrup Hospital, Copenhagen Center for Arthritis Research (COPECARE), Center for Rheumatology and Spine Diseases, Rigshospitalet - Glostrup, University of Copenhagen, Denmark, Glostrup, Denmark, 4Rheumatology, Research Unit at King Christian X Hospital for Rheumatic Diseases, Graasten, Denmark, 5DANBIO, Center for Rheumatology and Spine Diseases, Glostrup Univ Hospital, Glostrup, Denmark, 6Department of Radiology, Copenhagen University Hospital Herlev, Herlev, Denmark, 7Department of Rheumatology, Vejle Hospital, Vejle, Denmark

    Background/Purpose: Galectin-3 has been implicated as a mediator of inflammation and erosive progression in animal arthritis and rheumatoid arthritis(RA). The type IIA procollagen peptide(PIIANP) is…
  • « Previous Page
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

Embargo Policy

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM CT on October 25. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology